Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Goldman Sachs Raises Pearson And Informa

Tue, 17th Mar 2020 09:23

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

GOLDMAN SACHS RAISES PEARSON TO 'NEUTRAL' ('SELL') - PRICE TARGET 605 (505) PENCE

----------

GOLDMAN RAISES INFORMA TO 'NEUTRAL' ('SELL') - PRICE TARGET 729 (744) PENCE

----------

GOLDMAN CUTS RELX PRICE TARGET TO 2185.0 (2302.8) PENCE - 'BUY'

----------

GOLDMAN CUTS AUTO TRADER PRICE TARGET TO 653 (688) PENCE - 'BUY'

----------

GOLDMAN CUTS ITV PRICE TARGET TO 122 (147) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS WPP PRICE TARGET TO 900 (1045) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS FERGUSON PRICE TARGET TO 7100 (8100) PENCE - 'OVERWEIGHT'

----------

RBC CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 155 (200) PENCE - 'SECTOR PERFORM'

----------

RBC CUTS LLOYDS BANKING PRICE TARGET TO 47 (66) PENCE - 'OUTPERFORM'

----------

RBC CUTS HSBC PRICE TARGET TO 440 (520) PENCE - 'UNDERPERFORM'

----------

RBC CUTS BARCLAYS PRICE TARGET TO 120 (170) PENCE - 'SECTOR PERFORM'

----------

HSBC RAISES STANDARD CHARTERED TO 'HOLD' ('REDUCE') - TARGET 480 (590) PENCE

----------

HSBC CUTS WPP PRICE TARGET TO 620 (1030) PENCE - 'HOLD'

----------

JPMORGAN CUTS DIAGEO PRICE TARGET TO 2150 (2800) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS COCA-COLA HBC PRICE TARGET TO 1980 (3000) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1450 (1550) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS CUTS ASTRAZENECA PRICE TARGET TO 8000 (8500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS RECKITT BENCKISER PRICE TARGET TO 6500 (7700) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES UNILEVER TO 'NEUTRAL' ('UNDERWEIGHT') - PRICE TARGET 3850 (4210) PENCE

----------

JPMORGAN CUTS WHITBREAD PRICE TARGET TO 2990 (3800) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS INTERCONTINENTAL HOTELS TARGET TO 4150 (4600) P - 'UNDERWEIGHT'

----------

JPMORGAN CUTS COMPASS GROUP PRICE TARGET TO 1920 (2040) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES JUST EAT TAKEAWAY.COM TO 'BUY' ('HOLD') - PRICE TARGET 8000 PENCE

----------

FTSE 250

----------

GOLDMAN CUTS ASCENTIAL TO 'BUY' ('CONVICTION BUY') - PRICE TARGET 373 (569) PENCE

----------

KEPLER CHEUVREUX RAISES TATE & LYLE TO 'BUY' ('HOLD') - TARGET 720 PENCE

----------

LIBERUM CUTS BALFOUR BEATTY PRICE TARGET TO 320 (400) PENCE - 'BUY'

----------

LIBERUM CUTS EQUINITI PRICE TARGET TO 265 (275) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS HAMMERSON PRICE TARGET TO 200 (300) PENCE - 'BUY'

----------

HSBC CUTS 4IMPRINT GROUP PRICE TARGET TO 2215 (2820) PENCE - 'HOLD'

----------

JPMORGAN CUTS BRITVIC PRICE TARGET TO 875 (1065) PENCE - 'OVERWEIGHT'

----------

GOLDMAN CUTS HUNTING PRICE TARGET TO 160 (398) PENCE - 'SELL'

----------

GOLDMAN CUTS JOHN WOOD PRICE TARGET TO 282 (467) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES PETROFAC TO 'BUY' ('NEUTRAL') - TARGET 316 (433) PENCE

----------

JPMORGAN CUTS SSP GROUP PRICE TARGET TO 730 (790) PENCE - 'OVERWEIGHT'

----------

JEFFERIES CUTS SYNTHOMER PRICE TARGET TO 270 (375) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

GOLDMAN CUTS DAILY MAIL & GENERAL TRUST PRICE TARGET TO 632 (706) PENCE - 'SELL'

----------

LIBERUM CUTS KIER GROUP PRICE TARGET TO 115 (150) PENCE - 'BUY'

----------

BERENBERG CUTS BREEDON PRICE TARGET TO 105 (110) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.